Skip to main content

Kelon Morley Comment On Regulatory Notice 22-08

Comments:
As an individual investor who relies on leveraged and inverse ETFs to actively monitor and manage short term trading strategies, these instruments are critical to compliment more conventional products while providing desired exposure to targeted segments of the market. Notably, leveraged and inverse ETFs also provide an effective means to hedge other more conventional positions. The risks associated with leveraged and inverse ETFs are clearly identified by their providers and do not require additional regulatory complexity.

Jichang Guang Comment On Regulatory Notice 22-08

I oppose ANY restrictions to my right to invest in any securities publicly traded in US exchanges, including leveraged ETFs and inverted ETFs.

I believe that the investors know more about his/her selections of investment than the regulators. The proposed special processes are just unnecessary and, frankly, a bit stupid ways to assume the investors are inferior than regulators.

I strongly propose the regulators to discard any and all efforts to try to impose such restrictions. If they do, it will be definitely challenged by an class suite of all investors in US.

Martin Braun Comment On Regulatory Notice 22-08

Thank you for allowing us the opportunity to provide feedback regarding potential new security regulations. It is very important to the public that we maintain free and unincumbered securities markets. That means, yes, sometimes we may lose money on investments, but it is critical to protect the rights and abilities of investors' and individuals' to freely choose which securities they wish to buy, sell or hold including the ability to purchase inverse and leveraged products.